Electrochemiluminescence (ECL) has an inherently low background and enables precise chemical reactions through electrical control. Here, we report an advanced ECL system, termed ECLipse (ECL in paired signal electrode). We physically separated ECL generation from target detection: These two processes were carried out in isolated chambers and coupled through an electrode. The strategy allowed us to minimize cross-chemical reactions, design electrodes for high ECL signals, and integrate multiple sensors in a chip. As a proof of concept, we implemented an eight-plex ECLipse and applied it to detect host factors in human plasma. ECLipse achieved higher signal-to-noise ratio than conventional ECL assays and was >7000-fold more sensitive than enzyme-linked immunosorbent assay. In a pilot clinical study, we could detect septic conditions by measuring host factors [i.e., interleukin-3 (IL-3), IL-6, and procalcitonin (PCT)]. ECLipse assay further revealed distinct IL-3 and IL-6 patterns in patients with severe acute respiratory syndrome coronavirus 2 infection.
Despite growing interest, there is still no method available for ideal extracellular vesicle (EV) separation with satisfactory yield, purity, and user-friendly operation. Enrichment and purification of EVs are complicated by the fact that EVs are intrinsically heterogeneous in their size, density, and cargo, which makes separation of pure fractions of EVs empirically impossible. Therefore, it is at the discretion of the user to make a strategy for EV separation depending on the sample type, volume, and their downstream applications. Here, basic guidelines are provided to select a method for each type of biofluid, rating each method's performance in terms of total processing time, ease of use, feasible sample volume, yield, and purity of the concentrated EVs. The emerging technologies to achieve pure EVs and to unveil their heterogeneity are outlined together with the remaining challenges that need to be overcome.